Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganetespib and Paclitaxel in Platinum-Resistant Ovarian Cancer
NCT02012192Phase 2Terminated
- Sponsor
- Medical University of Innsbruck
- Start
- Jul 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of ganetespib in epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Medical University of Innsbruck. Started Jul 2014; status: terminated.
02
Drugs
ganetespib
03
Conditions
epithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02012192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02012192.